English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

AAC(6′)-Ib-cr is a plasmid-mediated quinolone resistance mechanism described worldwide forEscherichia coli . Since it confersin vitro only a low level of resistance to ciprofloxacin, we evaluated its impact on thein vivo activity of ciprofloxacin. Isogenic strains were obtained by transferring plasmid p449, harboringaac(6 ′)-Ib-cr , into the quinolone-susceptible strainE. coli CFT073-RR and its D87GgyrA mutant. MICs were 0.015, 0.06, 0.25, and 0.5 μg/ml againstE. coli strains CFT073-RR, CFT073-RR/p449, CFT073-RR GyrAr , and CFT073-RR GyrAr /p449, respectively. Bactericidal activity was reduced at 1× the MIC for the three resistant derivatives, while at a fixed concentration of 0.5 μg/ml, 99.9% killing was observed for all strains exceptE. coli CFT073-RR GyrAr /p449. In the murine model of pyelonephritis, an optimal regimen of ciprofloxacin (10 mg/kg of body weight twice a day [b.i.d.]) significantly decreased the bacterial count in the kidneys of mice infected withE. coli CFT073 (1.6 versus 4.3 log10 CFU/g of kidney compared to untreated controls;P = 0.0001), while no significant decrease was observed forE. coli CFT073-RR/p449 (2.7 versus 3.1 log10 CFU/g;P = 0.84),E. coli CFT073-RR GyrAr (4.2 versus 4.1 log10 CFU/g;P = 0.35), orE. coli CFT073-RR GyrAr /p449 (2.9 versus 3.6 log10 CFU/g;P = 0.47). While pharmacokinetic and pharmacodynamic (PK/PD) parameters accounted for ciprofloxacin failure againstgyrA -containing mutants, this was not the case for theaac(6 ′)-Ib-cr -containing strains, suggesting anin situ hydrolysis of ciprofloxacin in the latter case.

antimicrobial agents and chemotherapy

Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin <i>In Vitro</i>

Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin In Vitro